Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K(2(20)), on All-Trans Retinoic Acid-Resistant HL60 Cell Line

The first-choice drug for acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA), frequently causes drug-resistance and some adverse effects. Thus, an effective and safe agent for ATRA-resistant APL is needed. Menaquinone-4 (MK-4, vitamin K(2(20))), used for osteoporosis treatment, does...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pharmaceutics
Главные авторы: Yamakawa, Hirofumi, Setoguchi, Shuichi, Goto, Shotaro, Watase, Daisuke, Terada, Kazuki, Nagata-Akaho, Nami, Toki, Erina, Koga, Mitsuhisa, Matsunaga, Kazuhisa, Karube, Yoshiharu, Takata, Jiro
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161027/
https://ncbi.nlm.nih.gov/pubmed/34065416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050758
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы